Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1994 | 12-1993 | 12-1992 | 12-1991 | 12-1990 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 56,069 | -505,493 | 27,627 | 10,073 | -153,688 |
| Depreciation Amortization | 78,132 | 81,482 | 85,332 | 93,651 | 92,324 |
| Other Working Capital | 39,497 | 181,382 | 41,365 | 21,225 | 185,726 |
| Other Operating Activity | -11,079 | 325,389 | -12,103 | -15,212 | -64,481 |
| Operating Cash Flow | $162,619 | $82,760 | $142,221 | $109,737 | $59,881 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -116,070 | -110,630 | -100,761 | -95,333 | -82,894 |
| Net Acquisitions | 31,130 | 0 | -3,611 | -3,368 | -2,512 |
| Other Investing Activity | -11,228 | -6,272 | 32,394 | 28,985 | -1,274 |
| Investing Cash Flow | $-96,168 | $-116,902 | $-71,978 | $-69,716 | $-86,680 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -11,549 | 0 | 0 | 0 | 0 |
| Other Financing Activity | -91 | 73,337 | -77,305 | -47,654 | 25,470 |
| Financing Cash Flow | $-11,640 | $73,337 | $-77,305 | $-47,654 | $25,470 |
| Exchange Rate Effect | -602 | 0 | 0 | 0 | 0 |
| Beginning Cash Position | 43,509 | 4,314 | 11,376 | 19,009 | 20,338 |
| End Cash Position | 97,718 | 43,509 | 4,314 | 11,376 | 19,009 |
| Net Cash Flow | $54,209 | $39,195 | $-7,062 | $-7,633 | $-1,329 |
| Free Cash Flow | |||||
| Operating Cash Flow | 162,619 | 82,760 | 142,221 | 109,737 | 59,881 |
| Free Cash Flow | 162,619 | 82,760 | 142,221 | 109,737 | 59,881 |